Cytology-based cervical screening had unequivocal success in reducing the incidence and
mortality of cervical cancer in the last century. The recognition of the role of human …

Cervical cancer (CC) represents the fourth most common malignancy affecting women all
over the world and is the second most common in developing areas. In these areas, the …

This WHO and HRP guideline is designed to help countries make faster progress, more
equitably, on the screening and treatment of cervical cancer. It includes some important …

Abstract In 2020, the World Health Organization (WHO) launched a strategy to eliminate
cervical cancer as a public health problem. To support the strategy, the WHO published …

The incidence of cervical cancer in low‐and middle‐income countries (LMICs) is five times
higher than that observed in high‐income countries (HICs). This discrepancy is largely …

Purpose To provide resource-stratified, evidence-based recommendations on the secondary
prevention of cervical cancer globally. Methods ASCO convened a multidisciplinary …

Abstract HPV self-sampling (HPV-SS) can increase cervical cancer screening participation
by addressing barriers in high-and low-and middle-income settings. Successful …

The clearly higher sensitivity and reproducibility of human papillomavirus (HPV) DNA testing
for high-grade cervical intraepithelial neoplasia (CIN) has led to widespread calls to …

BACKGROUND The ARTISTIC (A Randomised Trial In Screening To Improve Cytology) trial
originally reported after two rounds of primary cervical screening with human papillomavirus …

Nepal has a high burden of cervical cancer primarily due to a limited screening program.
Most present with advanced cervical disease. Despite no national cervical cancer control …